[{"id":"a6fd23df-878e-47c4-a87e-35dde3ddcf83","acronym":"HS-20117","url":"https://clinicaltrials.gov/study/NCT06621563","created_at":"2025-02-26T15:00:47.900Z","updated_at":"2025-02-26T15:00:47.900Z","phase":"Phase 1","brief_title":"Phase Ib Trial of HS-20117 in Combination with Other Drugs in Advanced Solid Tumors","source_id_and_acronym":"NCT06621563 - HS-20117","lead_sponsor":"Hansoh BioMedical R\u0026D Company","biomarkers":" BRAF","pipe":"","alterations":" ","tags":["BRAF"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e cisplatin • carboplatin • 5-fluorouracil • PM1080 • risvutatug rezetecan (GSK5764227)"],"overall_status":"Not yet recruiting","enrollment":" Enrollment 780","initiation":"Initiation: 12/01/2024","start_date":" 12/01/2024","primary_txt":" Primary completion: 03/30/2026","primary_completion_date":" 03/30/2026","study_txt":" Completion: 12/01/2026","study_completion_date":" 12/01/2026","last_update_posted":"2024-10-01"}]